参考文献:1.Pommepuy N, Januel D. Catatonia: resurgence of a concept. A review of the international literature. Encéphale. 2002;28:481–92.PubMed 2.Gelenberg AJ. The catatonic syndrome. Lancet. 1976;1:1339–41.PubMed CrossRef 3.Huang TL, Ree SC, Huang YC, Liu HY, Yang YY. Catatonic features: differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci. 1999;53:63–6.PubMed CrossRef 4.Carroll BT, Spetie L. Catatonia on the consultation-liaison service: a replication study. Int J Psychiatry Med. 1994;24:329–37.PubMed CrossRef 5.Brelinski L, Cottencin O, Guardia D, Anguill JD, Queyrel V, Hatron PY. Catatonia and systemic lupus erythematosus: a clinical study of three cases. Gen Hosp Psychiatry. 1999;31:90–2. doi:10.1016/j.genhosppsych.2008.06.010 .CrossRef 6.Grover S, Parakh P, Sharma A, Rao P, Modi M, Kumar A. Catatonia in systemic lupus erythematosus: a case report and review of literature. Lupus. 2013;22:634–8. doi:10.1177/0961203313486951 .PubMed CrossRef 7.Rosenfeld MR, Dalmau J. Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Curr Treat Options Neurol. 2011;13(3):324–32. doi:10.1007/s11940-011-0116-y .PubMed PubMedCentral CrossRef 8.Mann A, Machado NM, Liu N, Mazin AH, Silver K, Afzal KI. A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature. J Neuropsychiatry Clin Neurosci. 2012;24:247–54. doi:10.1176/appi.neuropsych.11070151 .PubMed CrossRef 9.Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan V, Brewer GJ. The psychiatric presentations of Wilson’s disease. J Neuropsychiatry Clin Neurosci. 1991;3(4):377–82.PubMed CrossRef 10.Davis EJ, Borde M. Wilson’s disease and catatonia. Br J Psychiatry. 1993;162:256–9.PubMed CrossRef 11.Elia J1, Dell ML, Friedman DF, Zimmerman RA, Balamuth N, Ahmed AA, et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry. 2005;44(11):1145–50.PubMed CrossRef 12.Nayak RB, Shetageri VN, Bhogale GS, Patil NM, Chate SS, Chattopadhyay S. Catatonia: a rare presenting symptom of Wilson’s disease. J Neuropsychiatry Clin Neurosci. 2012;24(3):E34–5. doi:10.1176/appi.neuropsych.11070169 .PubMed CrossRef 13.Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233–41.PubMed CrossRef 14.Marra D, Amoura Z, Soussan N, Haroche J, Consoli A, Ghillami-Dalbin P, et al. Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus. Psychother Psychosom. 2008;77(3):195–6. doi:10.1159/000120280 .PubMed CrossRef 15.Lalanne L, Jantzi C, Gorse A, Zimmermann MA, Danion JM, Foucher J. Melancholia Associated With Severe Cognitive Disorders as the Expression of Late-Onset Postpartum Anti-N-Methyl-d-Aspartic Acid Receptor Limbic Encephalitis. J Neuropsychiatry Clin Neurosci. 2015;27(2):e168–9. doi:10.1176/appi.neuropsych.14040079 .PubMed CrossRef 16.Valdimarsdóttir U, Hultman CM, Harlow B, Cnattingius S, Sparén P. Psychotic illness in first-time mothers with no previous psychiatric hospitalizations: a population-based study. PLoS Med. 2009;6(2), e13. doi:10.1371/journal.pmed.1000013 .PubMed CrossRef 17.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994. 18.Tandon R, Heckers S, Bustillo J, Barch DM, Gaebel W, Gur RE, et al. Catatonia in DSM-5. Schizophr Res. 2013;150:26–30. doi:10.1016/j.schres.2013.04.034 .PubMed CrossRef 19.Yanagawa Y, Ohshita T, Takemoto M, Matsumoto N, Sakamoto T, Okada Y. A case of catatonia associated with the ingestion of hydroxyzine. No To Shinkei. 2005;57(1):45–9. Review.PubMed 20.Godfroid IO. Violence, desire and death. Reflections on 3 taboos in psychiatry. Encéphale. 2001;27(1):22–7.PubMed 21.Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012;137(1-3):151–8. doi:10.1016/j.schres.2012.02.012 .PubMed CrossRef 22.Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003;60:164–71.PubMed CrossRef 23.Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto’s encephalopathy (reccurent acute disseminated encephalomyelitis). Curr Med Chem. 2003;10(19):1945–53.PubMed CrossRef 24.Rodriguez AJ, Jicha GA, Steeves TD, Benarroch EE, Westmoreland BF. EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto’s encephalopathy). J Clin Neurophysiol. 2006;23:371–3.PubMed CrossRef 25.Ferraci F, Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol. 2006;253:975–84.CrossRef 26.Laske C, Leyhe T, Buchkremer G, Wormstall H. Depression in Hashimoto’s encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy. Nervenarzt. 2005;76(5):617–22.PubMed CrossRef 27.Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto’s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titer--report of 5 cases. Neurology. 1991;41:228–33.PubMed CrossRef 28.Brain L, Jellinek EH, Ball K. Hashimoto’s disease and encephalopathy. Lancet. 1966;2:512–4.PubMed CrossRef 29.de Holanda NC, de Lima DD, Cavalcanti TB, Lucena CS, Bandeira F. Hashimoto’s encephalopathy: systematic review of the literature and an additional case. J Neuropsychiatry Clin Neurosci. 2011;23(4):384–90. doi:10.1176/appi.neuropsych.23.4.384 .PubMed CrossRef 30.Muramatsu T, Ikawa M, Yoneda M, Sugimoto K, Matsunaga A, Yamamura O, et al. Pathophysiological decrease in the regional cerebral blood flow in Hashimoto’s encephalopathy: a multiple-case SPECT study. Eur Neurol. 2014;72(1-2):13–9. doi:10.1159/000358220 .PubMed 31.Bocchetta A, Tamburini G, Cavolina P, Serra A, Loviselli A, Piga M. Affective psychosis, Hashimoto’s thyroiditis, and brain perfusion abnormalities: case report. Clin Pract Epidemiol Mental Health. 2007;3:31. doi:10.1186/1745-0179-3-31 .CrossRef 32.Rolland F, Chevrollier JP. Depression, anti-thyroid antibodies and Hashimoto encephalopathy. Encéphale. 2001;27(2):137–42.PubMed 33.Babtain FA. Steroid responsive encephalopathy associated with autoimmune thyroiditis presenting with late onset depression. Neurosci (Riyadh). 2010;15(3):196–9. 34.Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, et al. Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand. 2014;129(3):163–79. doi:10.1111/acps.12211 .PubMed CrossRef 35.Hamdani N, Doukhan R, Kurtlucan O, Tamouza R, Leboyer M. Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr Psychiatry Rep. 2013;15(9):387. doi:10.1007/s11920-013-0387-y . Review.PubMed CrossRef 36.Lahutte B, Cornic F, Bonnot O, Consoli A, An-Gourfinkel I, Amoura Z, et al. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(6):1393–8. doi:10.1016/j.pnpbp.2008.02.015 .PubMed CrossRef
作者单位:Laurence Lalanne (1) (2) (5) Marie-Emmanuelle Meriot (1) Elisabeth Ruppert (3) (4) Marie-Agathe Zimmermann (1) Jean-Marie Danion (1) (2) Pierre Vidailhet (1) (2)
1. Department of Psychiatry, Fédération de Médecine Translationelle de Strasbourg (FMTS), University Hospital of Strasbourg, Strasbourg, France 2. INSERM 1114, Fédération de Médecine Translationelle de Strasbourg, University Hospital of Strasbourg, Strasbourg, France 5. INSERM1114-Department of Psychiatry, University of Strasbourg- 1 place de l’hôpital, 67000, Strasbourg, France 3. Department of Neurology, Sleep and Electrophysiology Clinic, Fédération de Médecine Translationelle de Strasbourg (FMTS), University Hospital of Strasbourg, Strasbourg, France 4. Institute for Cellular and Integrative Neurosciences, CNRS - UPR 3212, Fédération de Médecine Translationelle de Strasbourg (FMTS), 67084, Strasbourg, France
刊物主题:Psychiatry; Psychotherapy;
出版者:BioMed Central
ISSN:1471-244X
文摘
Background Catatonia is a neuropsychiatric syndrome with motor and behavioural symptoms. Though usually occuring in patients with schizophrenia and mood disorders, this syndrome may also be associated with neurological diseases or general medical conditions. Few cases of catatonia associated with autoimmune disorders have been described.